-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Feb 10, 16:01Prev. Close
1290.00
Open Price
1300.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 10, 15:42Prev. Close
1299.70
Open Price
1329.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of HALEOS LABS (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 3.02 | 3.02 | 3.02 | 0.01 | 0.01 | |
| Total Share Capital | 3.02 | 3.02 | 3.02 | 0.01 | 0.01 | |
| Reserves and Surplus | 110.23 | 101.96 | 85.38 | 81.83 | -0.02 | |
| Total Reserves and Surplus | 110.23 | 101.96 | 85.38 | 81.83 | -0.02 | |
| Total Shareholders Funds | 113.26 | 104.98 | 88.41 | 81.84 | -0.01 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 23.67 | 27.20 | 15.19 | 15.96 | 0.00 | |
| Deferred Tax Liabilities [Net] | 8.73 | 7.97 | 7.17 | 7.61 | 0.00 | |
| Other Long Term Liabilities | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 2.59 | 2.24 | 2.00 | 1.83 | 0.00 | |
| Total Non-Current Liabilities | 35.93 | 37.42 | 24.36 | 25.41 | 0.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 20.96 | 12.77 | 5.99 | 4.04 | 0.00 | |
| Trade Payables | 45.33 | 83.46 | 44.39 | 55.40 | 0.01 | |
| Other Current Liabilities | 12.64 | 11.47 | 12.91 | 8.08 | 0.00 | |
| Short Term Provisions | 0.83 | 0.60 | 0.60 | 0.47 | 0.00 | |
| Total Current Liabilities | 79.77 | 108.30 | 63.89 | 68.00 | 0.01 | |
| Total Capital And Liabilities | 228.95 | 250.70 | 176.65 | 175.24 | 0.00 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 94.31 | 87.09 | 68.36 | 72.68 | 0.00 | |
| Intangible Assets | 0.18 | 0.04 | 0.02 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 2.47 | 1.31 | 7.09 | 0.17 | 0.00 | |
| Other Assets | 0.00 | 0.91 | 0.80 | 0.81 | 0.00 | |
| Fixed Assets | 96.96 | 89.36 | 76.27 | 73.66 | 0.00 | |
| Non-Current Investments | 25.81 | 25.98 | 5.00 | 0.04 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 2.92 | 0.00 | |
| Other Non-Current Assets | 4.96 | 5.83 | 6.66 | 4.72 | 0.00 | |
| Total Non-Current Assets | 127.74 | 121.17 | 87.94 | 81.34 | 0.00 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 61.05 | 73.87 | 49.32 | 43.79 | 0.00 | |
| Trade Receivables | 22.02 | 36.58 | 27.08 | 39.03 | 0.00 | |
| Cash And Cash Equivalents | 2.30 | 2.47 | 0.76 | 0.08 | 0.00 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 15.84 | 16.62 | 11.57 | 11.00 | 0.00 | |
| Total Current Assets | 101.21 | 129.54 | 88.72 | 93.90 | 0.00 | |
| Total Assets | 228.95 | 250.70 | 176.65 | 175.24 | 0.00 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 83.16 | 54.17 | 41.01 | 65.42 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 48.32 | 98.76 | 69.07 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.69 | 2.09 | 1.17 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 86.82 | 163.55 | 107.21 | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 25.81 | 25.98 | 5.00 | 0.04 | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
17.11.2025
SMS Lifescience Consolidated September 2025 Net Sales at Rs 81.37 crore, up 3.7% Y-o-Y
12.11.2025
SMS Lifescience Standalone September 2025 Net Sales at Rs 77.84 crore, down 0.83% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017
